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Abstract
Establishment of stable HIV-1 infection requires the efficient integration of the retroviral genome into the host DNA. The
molecular mechanism underlying the control of this process by the chromatin structure has not yet been elucidated. We
show here that stably associated nucleosomes strongly inhibit in vitro two viral-end integration by decreasing the
accessibility of DNA to integrase. Remodeling of the chromatinized template by the SWI/SNF complex, whose INI1 major
component interacts with IN, restores and redirects the full-site integration into the stable nucleosome region. These effects
are not observed after remodeling by other human remodeling factors such as SNF2H or BRG1 lacking the integrase binding
protein INI1. This suggests that the restoration process depends on the direct interaction between IN and the whole SWI/
SNF complex, supporting a functional coupling between the remodeling and integration complexes. Furthermore, in silico
comparison between more than 40,000 non-redundant cellular integration sites selected from literature and nucleosome
occupancy predictions also supports that HIV-1 integration is promoted in the genomic region of weaker intrinsic
nucleosome density in the infected cell. Our data indicate that some chromatin structures can be refractory for integration
and that coupling between nucleosome remodeling and HIV-1 integration is required to overcome this natural barrier.
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Introduction
The integration of viral DNA into the cellular genome is a key
mechanism for the establishment of stable HIV-1 infection. This
multi-step mechanism catalyzed by the retroviral integrase (IN) is
divided into the 39processing of two viral DNA ends followed by
their strand transfer into the target DNA. These reactions can be
reproduced in vitro independently [1–3] or in concerted integration
[4–6]. However, conditions in cells differ in numerous ways from
these in vitro reactions. For example, in infected cells, IN is
associated with other viral and cellular factors and the viral DNA
in a large nucleoprotein complex called the pre-integration
complex (PIC) [7]. Furthermore, target DNA is ensconced within
chromatin, a highly structured nucleoprotein complex that
modulates DNA accessibility to various nuclear proteins or
enzymes and can thus affect the efficiency and selectivity of
retroviral integration [8–12]. Retroviruses target different regions
of the genome. For example, HIV-1 preferentially integrates into
active genes [13,14] in contrast to Mo-MLV and ASLV, which
displays less preference for active genes containing regions [15,16].
The effects of the chromatin structure on integration are thought
to be responsible for the different selectivity of retroviral integrases.
This was confirmed by the finding that DNA compaction by
histone H1 affected differently the in vitro one-end integration
catalyzed by HIV and ASV INs [17]. Functional studies show that
the integrase protein appears to be the principle viral determinant
responsible for this differential DNA targeting during integration
[18]. More recent massive analyses of retroviral DNA integration
using the pyrosequencing method better described the cellular
chromatin landscape of the integration loci [12,19,20]. Those
studies indicate that integration is particularly promoted near
transcription-associated histone modifications but was not pro-
moted in regions rich in transcription-inhibiting modifications.
This property of HIV-1 IN to integrate fairly equally into the
active gene, in addition to the integration sites profile observed in
infected cells, suggests a link between IN and the cellular
chromatin machinery. This is supported by the fact that several
well described IN cofactors, as INI1 and LEDGF/p75, belong to
the chromatin associated proteins family. INI1, is a core
component of the chromatin remodeling complex SWI/SNF that
directly interacts with HIV-1 IN [21], either stimulates or inhibits
in vitro integration and modulates several steps of the HIV-1
replication in cells [22–24]. The lens epithelium-derived growth
factor (LEDGF/p75) is another major IN cofactor essential for
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efficient retroviral replication [15,25–27] and involved in the
choice of integration sites [15,28,29]. Interestingly, affecting the
selectivity of LEDGF/p75 can modify the selectivity of HIV-1 IN
and provide new tools for gene therapy lentiviral vectors [30–33].
Taken together all those data support a functional interaction
between the retroviral integration machinery and cellular factors
modifying or sensing histone modifications associated with the
transcription process. However, the molecular mechanism underly-
ing the efficient integration into the chromatin structure has not yet
been elucidated. An in vitro integration assay using linear polynucleo-
somes as acceptor templates made it possible to study the effect of
chromatin on half-site one-end integration (HSI) and the regulating
function of LEDGF/p75 [34]. However, it was not possible to
determine the impact of chromatin on the physiological two viral-end
full-site integration reaction (FSI) undetectable in this system. To
analyze both the efficiency and the selectivity of HIV-1 integration
into chromatin, we used a circular chromatinized substrate to detect
both FSI and HSI forms. We report here for the first time that, in
contrast to HSI, efficient FSI integration is disfavored in areas of
stable and regularly positioned nucleosomes, and that chromatin
remodeling of these domains mediated by the SWI/SNF complex
containing IN cofactor INI-1 is required to overcome this barrier.
Results
In vitro assembled nucleosomes array is refractory to full-
site concerted integration but not half-site integration
The circular chromatinized acceptor pBSK-Zeo-5S-G5E4
vector described in Figure 1A was constructed by cloning the
5S-G5E4 nucleosome positioning sequence reported in Figure 1B
into the previously described pBSK-Zeo backbone [35]. The 5S-
G5E4 fragment contains 265 nucleosome positioning sequences
(5S) that allow the in vitro assembly of a stable and regularly spaced
polynucleosome (PN) template. This PN has been extensively used
to study chromatin remodeling, histone modifications and several
enzymatic processes occurring on chromatin in vitro [36–38]. The
structure of the chromatinized plasmid was first predicted in silico
using the nucleosome occupancy prediction algorithm described in
[39] and derived from [40]. The analysis reported in Figure 1C
suggests that the circular PN assembled on the pBSK-Zeo-5S-
G5E4 vector contains two different chromatin regions: stably
positioned and regularly spaced nucleosomes in region I and less
dense and more dynamic nucleosomes in region II. The formation
of two distinct chromatin structures was experimentally confirmed
by typical restriction enzyme assay (REA) using enzymes cleaving
in region I, region II or in both regions (cf restriction site positions
in Figure S1A). Results showed highly reproducible differences in
restriction site accessibility in both regions after nucleosome
assembly (Figure 1D). Correct positioning of the nucleosomes on
in the 5S-G5E4 region was further controlled by specific EcoRI
cleavage of the region followed by agarose gel shift allowing to
precisely detect mono- and di-nucleosomes on well assembled
templates (Figure S1B). The naked and plasmid PN assembled
with increasing DNA/histones were therefore used as acceptor
templates in concerted integration assays in order to determine the
effect of these chromatin structures on the selectivity and the
efficiency of both half-site and full-site integration.
Integration assays were performed using the unprocessed SupF
donor DNA and the naked or PN pBSK-zeo-5S-G5E4 templates.
Experimental procedure and analysis of the integration products
were performed as previously reported [35] (the result of a typical
concerted integration reaction is provided in Figure S2). We first
observed a large DNA/histone ratio-dependent inhibition of the
linear FSI products formed on the PN templates compared to the
FSI products formed on the naked vector (Figure 2A and
quantification in 2B). In contrast, the circular HSI+FSI products
were less affected by the PN assembly. The cloning and the specific
quantification of the circular FSI integration products showed that
FSI efficiency was severely impaired on the PN substrate
(Figure 2C). No significant change in the fidelity of the integration
reaction was detected for each condition, as reported in the
integration loci structure determination by sequencing (Figure S3).
Data were highly reproducible on multiple independent sets of
chromatinized templates. However, the inhibition efficiency did
vary from one set to another depending on the efficiency of the
nucleosome positioning on the template controlled by restriction
analysis reported in Figure 1D and Figure S1B. Control
experiments performed with purified histones added in standard
integration reaction solutions did not show any significant inhibition
except using excess amounts of protein (data not shown) indicating
that the inhibition observed with the PN template was not due to the
free unbound histones remaining in the solution after assembly.
This was confirmed by the results of integration assays performed
with the pBSK-zeo vector lacking the 5S-G5E4 sequence and
assembled with the same amounts of histones (checked by typical
REA assay). Indeed, in this case, no inhibition was found as it would
be expected if due to free histones (Figure S4).
In order to determine whether this inhibition profile was
dependent on the way the nucleosomes were assembled on the
templates we tested other differently assembled PN on integration.
An assembly method based on the use of Acf1/ISWI complex in
presence of recombinant histone chaperone NAP-1 and topo-
isomerase was chosen since in this case the nucleosome positioning
mechanism is highly different from the one followed by salt dialysis
[41]. As checked by REA assay (Figure S5A) with this system 1/
0.1 to 1/0.6 DNA/histone ratios (w/w) could be efficiently
assembled. The same integration inhibition effect of the
nucleosomes was observed using these new PN (Figure S5B)
indicating that positioned nucleosomes inhibited in vitro integration
on DNA templates independently from the assembly method. The
Author Summary
The infection and pathogenicity of HIV-1 requires the
integration of a DNA copy of its genome into host cell
chromosomes. This leads to a stable association between
the host and the retrovirus, preventing its total eradication
from the patient and the constant archiving of drug-
resistant viruses. Even if the reaction mechanism catalyzed
by the viral integrase is now well known, its interaction
with the host chromatin is incompletely understood.
Chromatin is highly structured due to DNA compaction
in nucleosomes where the DNA accessibility can affect
both the efficiency and the selectivity of integration. Using
an in vitro assay allowing us to reproduce and monitor
easily the integration into an acceptor chromatinized
plasmid, we show that the presence of a stable and
organized nucleosome prevents the integration of the viral
DNA. Additionally, we report that the integration into
nucleosome regions can be restored if it is coupled with
cellular factors that remodel the chromatin structure. Our
results indicate a strong functional interaction between
the HIV-1 integration complex and the chromatin mainte-
nance host machinery required for efficient integration of
the HIV-1 genome into the cellular DNA. This suggests
potentially new therapeutical targets for inhibiting HIV-1
replication, and also potentially new ways for modulating
the selectivity of the lentiviral vector-mediated integration
in gene therapy.
HIV-1 Integration into Stable Chromatin
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salt dialysis method was chosen for the next steps of study because
of its better compatibility with extensive analyses and the absence
of assembly factor that could interfere with the following
integration reaction.
Stable and regularly spaced nucleosomes strongly inhibit
full-site integration in vitro
The integration inhibition observed in PN templates could
result from modifications in the DNA topology of the receptor
plasmid. To test this hypothesis, the PN templates were relaxed by
Topoisomerase I before to be used as acceptor substrates. As
shown in Figure S6, no drastic change in the global inhibition
profile was observed after Topoisomerase I treatment. This
confirmed the results obtained in control experiments using the
assembled pBSK-zeo vector. Indeed when integration was
performed on these templates no significant inhibition of both
HSI and FSI was detected (see Figure S4). Taken together, our
data led us to conclude that the inhibition of concerted integration
by the nucleosomes was mainly due to the stable nucleosomes
assembled in region I (absent in pBSK-ZEo vector) and not to
massive changes in DNA topology of the chromatinized plasmids
(expected to occur at a similar level in pBSK-zeo and pBSK-zeo-
5S-G5E4 chromatinized vectors).
If physical protection of the DNA by the nucleosomes is
responsible for the inhibition of FSI integration in region I, then
we should observe a correlation between the density of integration
sites and the accessibility of restriction sites throughout the
chromatinized vector (reported in Figure 1D). Thus, a greater
protection of integration is expected in region I compared to
region II. To elucidate this point, integration loci found in the
circular FSI products obtained on the PN pBSK-zeo-5S-G5E4
template were sequenced. A PN acceptor template assembled with
a 1/1.67 DNA/histone ratio (w/w) was chosen since enough
integrants could be selected in bacteria for further analysis, even if
strong inhibition of FSI was observed under these conditions
(Figure 2C). Under these conditions, in contrast to the corre-
sponding naked DNA vector, a large redistribution of the
integration loci outside the 5S-G5E4 region I was observed
(Figure 2D and integration loci localization in Figure S7).
Figure 1. Structure of the pBSK-zeo-5S-G5E4 chromatinized acceptor DNA. The pBSK-zeo-5S-G5E4 vector (A) contains the previously
described 5S-G5E4 phasing region (B) and an outer region without phasing sequence (pBSK-zeo backbone) containing the Sh ble gene and EM-7
promoter. The grey ovals represent the 5S RNA stably positioned nucleosomes, black ovals represent two nucleosomes covering five Gal 4 binding
sites and adenovirus 2 E4 minimal promoter. Arrows show the EcoRI sites containing regions. Nucleosome stability and positioning on the vector was
predicted using the model described by [39] (C). The energy of nucleosome formation was plotted for each position of the template sequence. Two
regions were determined: region I containing stably and regularly associated nucleosomes and region II with more labile nucleosomes. The structure
of the two regions was further checked by REA assay (D) using enzymes cleaving in region I, II or both and the percentage of cleavage was reported
as the result of a typical representative experiment.
doi:10.1371/journal.ppat.1001280.g001
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Treatment of PN templates with the human SWI/SNF
chromatin remodeling complex restores and re-directs
full-site integration into the dense nucleosome region
Since the DNA protection by the nucleosome was probably
responsible for the integration refractory property of region I, we
wondered whether nucleosome remodeling could restore integra-
tion into the stable chromatin domain.
Remodeling of nucleosomes can be conducted by several
protein complexes in the cell (for a review see [42]). We focused
here on the human SWI/SNF complex since a major component
of this complex, INI1, interacts with HIV-1 IN and is thought to
regulate its activity both in vitro and in functional cellular assays
[21,43–45]. The human SWI/SNF complex was purified from
HeLa cells following well defined a previously published
purification protocols allowing to obtain an active complex
without major contaminants [46]. The remodeling activity of the
purified complex was checked on our chromatinized integration
templates under conditions described previously [47] using REA
assay (S8A).
To determine the effect of this remodeling activity on concerted
integration, both reactions were coupled. Briefly, acceptor
plasmids were treated with the purified SWI/SNF complex and
then IN was added to the reaction solution under conditions
allowing the integration reaction. As shown in Figure 3A,
remodeling of the PN templates by SWI/SNF led to recovery of
full-site integration on these templates. Same results were obtained
with the other PN (S8B). Quantification of the circular FSI
products in bacteria confirmed the integration recovery after
SWI/SNF treatment (Figure 3B). Additional gel filtration
purification of the SWI/SNF complex followed by the assay of
the eluted fractions in IN-mediated concerted integration into PN
showed that the integration restoration activity co-purified with
the active remodeling complex. This led us to rule out the possible
contaminant source for the restoration effect (data not shown).
Figure 2. Effect of nucleosome assembly on in vitro HIV-1 integration. A concerted integration assay was performed with 12 pmoles of IN
and 10 ng of donor DNA and 100 ng of naked pBSK-zeo-5S-G5EA plasmid (Naked), or polynucleosomal pBSK-zeo-5S-G5E4 assembled with increasing
amounts of histones expressed in DNA/histones mass ratio (mg/mg) (1/1, 1/33, 1/167, 1/2). The reaction products were loaded on 1% agarose gel (A).
The position and structures of the donor substrate and different products obtained after half-site (HSI), full-site (FSI) and donor/donor integration (d/
d) are shown. The different integration products were quantified by densitometric estimation of the FSI and HSI+FSI heterointegration bands with the
Image J software (B). The circular FSI products were specifically quantified by cloning in bacteria and reported as the number of ampicillin-,
kanamycin- and tetracycline-resistant selected clones (C). FSI products obtained after integration into the naked or PN 1/1.67 vector were sequenced
and 20 correct integration loci were localized in the vector sequence. Results are reported as number of integrations per 100 bp of DNA for region I
containing the stably assembled nucleosomes and region II carrying more labile nucleosomes (D). All the values correspond to the mean 6 standard
deviation (error bars) of three independent sets of experiments.
doi:10.1371/journal.ppat.1001280.g002
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Sequencing of the integration loci was then performed in order
to analyze the effect of SWI/SNF remodeling on the selectivity of
FSI. We found that remodeling of the PN assembled on the pBSK-
zeo-5S-G5E4 vector was responsible for a global restoration of FSI
integration and an important re-direction of the integration events
into region I (Figure 3C). On the other hand, there was no change
in integration fidelity (Figure S8C). In contrast, incubation of the
naked pBSK-zeo-5S-G5E4 vector with the SWI/SNF remodeling
complex did not change the random distribution of the integration
sites (shown in Figure 2D) and the proportion of integration sites in
region I of this vector was not increased. This result confirms that
the restoration of integration within the 5S-G5E54 region after
remodeling requires its chromatinization. The molecular mecha-
nism underlying this change of integrase selectivity was then
studied.
Full-site integration into stable nucleosomes requires the
whole active SWI/SNF complex
We first tested whether the remodeling activity of the SWI/SNF
complex was required for both integration restoration and
targeting into stable nucleosomes. As known and confirmed in
the REA assay reported in Figure S8A, the remodeling activity of
this complex requires ATP. When integration experiments were
performed using PN templates treated with SWI/SNF in the
Figure 3. Effect of chromatin remodeling activity of the SWI/SNF complex on the in vitro integration in nucleosomal templates.
Naked or chromatinized pBSK-zeo-5S-G5EA vector was used as acceptor substrate in a concerted integration assay performed after SWI/SNF
treatment in presence of ATP (0 to 120 minutes) with 12 pmoles IN, 10 ng donor and 100 ng acceptor. Efficient remodeling of the vector was
previously checked by REA assay (see Figure S6A). The reaction products were loaded on 1% agarose gel and an example of the result obtained with
the 1/1.67 PN template is reported in (A). The position the different products obtained after half-site (HSI), full-site (FSI) and donor/donor integration
(d/d) are shown in addition to donor (d). The circular FSI products obtained with vectors assembled with increasing amounts of histones expressed in
DNA/histones mass ratio (mg/mg) (1/33, 1/167, 1/2) with or without SWI/SNF pre-treatment were specifically quantified by cloning in bacteria and
reported as the number of ampicillin-, kanamycin- and tetracycline-resistant selected clones (B). 20 correct integration loci were localized in the
vector sequence and the number of integration events obtained with the naked or 1/1.67 PN template remodeled by SWI/SNF was quantified and is
shown as integration number per 100 bp of DNA for region I containing the stably assembled nucleosomes and region II carrying more labile
nucleosomes (C). All the values are the mean 6 standard deviation (error bars) of three independent sets of experiments.
doi:10.1371/journal.ppat.1001280.g003
HIV-1 Integration into Stable Chromatin
PLoS Pathogens | www.plospathogens.org 5 February 2011 | Volume 7 | Issue 2 | e1001280
absence of ATP, neither the restoration of integration (Figure 4A)
nor its targeting towards region I (Figure 4B and integration loci
localization in Figure S9) was observed. This result points out the
ATP dependence of the integration restoration and strongly
suggests that SWI/SNF nucleosome remodeling activity is
required for the process.
Owing to the direct interaction between IN and INI1, a
component of the SWI/SNF complex [21], the most reasonable
hypothesis explaining our observations would be a direct
interaction between IN and the active SWI/SNF complex, leading
to a functional coupling between its nucleosome remodeling
property and the integration reaction. In vitro immunoprecipitation
between the recombinant purified IN and the SWI/SNF complex
(Figure 5A) supported this hypothesis and led us to assume that the
binding of IN to the remodeling complex occurred via the INNINI1
interaction reported above and also observed in our conditions
(Figure 5B). To determine whether this interaction was sufficient
for the restoration and targeting process, we tested the effect of the
isolated INI1 factor on concerted integration into PN substrates.
As shown in Figure 5D, treatment of the PN substrate with INI1
did not make it possible to overcome the inhibitory effect of the
nucleosomes, as observed with the entire remodeling complex.
Therefore, the INNINI1 interaction was not sufficient to restore an
efficient concerted integration into the chromatinized template
confirming the requirement of a coupling between integration and
the remodeling activity.
Restoration of integration into stable nucleosomes
involves the direct binding of IN to SWI/SNF complex
To determine whether this coupling needs a direct interaction
between HIV-1 IN and the remodeling complex we first tested
another human remodeling enzyme that doesn’t bind IN. The
SNF2H enzyme was chosen since it is the catalytic subunit of the
human ACF/SNF2H chromatin remodeling complex, another
main human chromatin remodeling complex [48] and no direct in
vitro interaction was found between the purified SNF2H and HIV-
1 IN in immunoprecipitation experiments (Figure 5C). Addition-
ally the remodeling efficiency of SNF2H on the pBSK-zeo-5S-
G5E4 PN templates was found similar to the one detected for
SWI/SNF (see Figure S10). Thus we tested the effect of SNF2H
remodeling on integration restoration into PN templates and
compared it with the one detected with SWI/SNF. Integration
experiments showed that, despite the capability of SNH2H to
remodel the PN template, no restoration of activity was observed
after this treatment in contrast to SWI/SNF (Figure 5D). However
the lack of restoration with SNF2H could be due to some
differences in the remodeling process catalyzed by this factor
comparing to SWI/SNF [49,50]. To better address the specificity
of the restoration observed with SWI/SNF and to determine the
role of INNSWI/SNF interaction in this mechanism, we tested the
isolated catalytic BRG1 subunit of this complex which was
previously shown to possess a remaining remodeling activity [50]
but lacks the integrase binding INI1 cofactor (no direct interaction
between HIV-1 IN and BRG1 protein was detected under our
immunoprecipitation conditions).
We first checked the remodeling activity of BRGI on our PN
templates. Our remodeling assays indicated that even if BRGI
displayed similar activity than SWI/SNF on linear PN template it
was less active on our circular PN at high DNA/histones ratios
(.1/1.33, data not shown). However similar remodeling efficiency
was found for BRGI and the whole complex at moderate ratios
(see Figure 6A). Thus a 1/1.33 DNA/histones ratio was chosen for
analyzing the effect of BRG1 remodeling on the in vitro integration.
As reported in Figure 6B, in contrast to SWI/SNF treatment, no
restoration of integration was detected with BRG1 despite the
similar remodeling activity found between the two complexes.
This indicates that efficient integration into PN requires both
the remodeling activity of SWI/SNF and its direct interaction with
HIV-1 IN. This data provides evidence for a model where a direct
Figure 4. Effect of ATP on the in vitro integration restoration and targeting property of the SWI/SNF complex. A concerted integration
assay was performed with 12 pmoles of IN and 10 ng of donor DNA and 100 ng of naked or PN pBSK-zeo-5S-G5E4 treated or not for 2 hours with
SWI/SNF complex in presence or absence of ATP. The circular FSI reaction products obtained in each condition were specifically cloned and
quantified in bacteria as the number of ampicillin-, kanamycin- and tetracycline-resistant selected clones (A). 20 correct integration loci were localized
in the vector sequence and the number of integration events obtained with the PN 1/1.67 vector treated with SWI/SNF in presence or absence of ATP
were sequenced and reported as integration number per 100 bp of DNA for region I containing stable nucleosomes and region II containing more
labile nucleosomes (B). Values correspond to the mean 6 standard deviation (error bars) of three independent experiments.
doi:10.1371/journal.ppat.1001280.g004
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functional coupling between HIV-1 IN and the entire active SWI/
SNF complex is required for efficient in vitro integration a
nucleosome-dense region. To further evaluate this refractory
property of nucleosomes in cells we analyzed the position of
several integration sites identified in the genome of infected cells
and compared them with the nucleosome positions on the
genome.
HIV-1 integration into transcriptional units of infected
cells is favored in less dense nucleosome regions
HIV-1 integration has been shown to be favored in transcrip-
tional units [12,19,20]. We further compared the positions of
integration sites and nucleosomes in both transcription units and
intergenic regions. For this analysis, the sequences surrounding 41
435 non redundant integration sites were selected from previous
studies [12] and submitted to a nucleosome-positioning predictive
algorithm [39]. The probabilities of nucleosome occupancy were
calculated along the 41 435 selected sequences and averaged using
the integration sites to align the sequences. The average profile
presented in Figure 7 clearly shows that HIV-1 integration sites
are mainly found in sequences with lower nucleosome occupancy
(0.69) in both genic and intergenic regions as compared to the
mean occupancy found at distal sites (0.72 at 10 kbp). This result
obtained on a genomic scale with actual HIV-1 integration sites
confirms that nucleosome-dense regions are refractory to HIV-1
integration, as observed in our in vitro assays of concerted
integration into chromatinized templates.
Discussion
The relationship between HIV-1 integration and cellular DNA
structure is poorly documented mostly owing to the lack of
efficient in vitro systems to address this question. We constructed an
in vitro acceptor circular DNA substrate containing two differently
chromatinized regions: a 5S-G5E4 nucleosome phasing domain
(region I) where histones are found in highly dense, stable and
regular association with DNA, and an outer domain (region II)
where nucleosomes are less dense and irregularly spaced in
dynamic complexes. The differential structure of these regions was
confirmed both by REA assay and by nucleosome-positioning
prediction. Using this template, we analyzed the effect of these two
chromatin structures on both HSI and FSI integration events.
Quantification of the efficiencies of these activities showed that,
unlike HSI, the physiological FSI reaction was severely impaired
by nucleosomes. Moreover, the sequencing of the integration loci
in the chromatinized plasmid confirmed that the stable nucleo-
some region I was strongly refractory to two viral-end concerted
integration, in contrast to the outer region II containing less stable
histones/DNA complexes. Importantly, in all the conditions used
Figure 5. Physical and functional in vitro interaction between HIV-1 IN and human SWI/SNF complex, INI1 protein or SNF2h.
Recombinant pure HIV-1 IN and SWI/SNF complex were subjected to co-immunoprecipitation analysis using a-BAF57 antibodies (A).
Immunoprecipitation without antibody was used as control (Beads). The initial amount of protein used is shown (Input). Recombinant pure HIV-1
integrase and FLAG-tagged INI1 were subjected to immunoprecipitation using a-FLAG or no antibodies (Beads) (B). Recombinant pure HIV-1
integrase and FLAG-tagged INI1 were subjected to immunoprecipitation using a-FLAG or no antibodies (Beads). Recombinant pure HIV-1 integrase
and FLAG-tagged INI1 were subjected to immunoprecipitation using a-FLAG or no antibodies (Beads). Bound proteins and input controls were
immunoblotted with a-BAF57, a-FLAG or a-IN antibodies. Recombinant pure HIV-1 integrase and SNF2H proteins were subjected to co-
immunoprecipitation using a-SNF2H or no antibody as control (Beads) (C). Initial amount of protein used is shown (Input). Bound proteins and input
controls were immunoblotted with a-SNF2H or a-IN antibodies. In all panels, WB= Western blot analysis. Functional interactions were studied in a
concerted integration assay performed with 12 pmoles of IN and 10 ng of donor DNA and 100 ng of naked or PN pBSK-zeo-5S-G5E4 assembled with
increasing amounts of histones expressed in DNA/histones mass ratio (mg/mg) (1/33, 1/167, 1/2) treated or not for 2 hours with SWI/SNF complex or
FLAG-tagged INI1 under the same conditions in presence of ATP (D). The FSI products were quantified by densitometric estimation of the linear FSI
bands with the Image J software and reported as percentage of integration. Values correspond to the mean 6 standard deviation (error bars) of at
least three independent experiments.
doi:10.1371/journal.ppat.1001280.g005
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in this study, only the efficiency of the integration reaction was
affected by nucleosomes in contrast to integration fidelity. This
indicates that the nucleosomes did not affect the quaternary
structure of the incoming active integration complexes, which was
previously shown to strongly impact the fidelity of the integration
reaction [51].
This inhibition was found independent of the nucleosomes
assembly method. Furthermore, no inhibition of integration was
observed in the chromatinized pBSK-zeo lacking the 5S-G5E4
region and the relaxation of the chromatinized pBSK-zeo-5S-
G5E4 vector by topoisomerase I, didn’t change the efficiency of
integration in this PN. Therefore, the inhibition observed on the
chromatinized pBSK-zeo-5S-G5E4 vector was due to the stably
associated nucleosomes in the 5S-G5E4 region I and not to DNA
topology changes induced by nucleosome assembly. In contrast,
the outside pBSK-zeo backbone region II containing more labile
nucleosomes was less refractory to the integration catalyzed by
HIV-1 IN.
These results first appeared contradictory with previously
reported data [8,52], indicating that nucleosomes were preferred
Figure 6. Comparison between the effect of nucleosome remodeling by BRG1 or SWI/SNF on in vitro integration into PN. Naked or 1/
1.33 DNA/histones mass ratio (mg/mg) chromatinized pBSK-zeo-5S-G5EA vectors were treated with 0.6 pmoles of BRG1 for two hours. The remodeling
efficiency was controlled in a REA assay (here HhaI restriction) (A). Naked or chromatinized vector were used as acceptor substrate in a standard
concerted integration assay performed without remodeling treatment or after SWI/SNF or BRGI. Heterointegration products were quantified on
agarose gel using the Image J software and reported as percentage of integration. The results of a typical representative REA experiment is shown in
A and the data are reported as percentage of DNA cleaved. The means of three in vitro integration experiments were reported in B and data were
compared to a 100% of integration corresponding to the standard integration conditions (naked DNA without treatment).
doi:10.1371/journal.ppat.1001280.g006
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target for in vitro integration. However substantial differences exist
between our present study and these works including the different
origin of the analyzed integrases (MLV versus HIV) and their
difference in selectivity. Furthermore, even if the two integration
mechanisms are similar, some important features diverge: the two
proteins do not interact with the same cofactors (no interaction
with LEDGF and INI1 were described for MLV) and MLV and
HIV do not integrate with the same stagger. This stagger could
induce different constraints that, in the case of HIV, could not be
compatible with integration into nucleosomes. Finally the works
performed previously did not distinguish the partial HSI and the
real FSI integration and our data show that the prerequisites for
integration into chromatin are not the same for the HSI and FSI
reactions.
Indeed, on stable nucleosomes assembled on positioning
sequences (region I), we observed a clear difference between the
efficiencies of HSI and FSI. This result suggests that the
accessibility of the two strands of the DNA helix all along the
nucleosome structure, does not fit with the structural requirement
for an efficient FSI reaction. The requirement for HSI is different,
as shown in several previous studies, and corresponds to
phosphodiester bounds located in enlarged DNA major grooves
facing out the histone octamer. This difference between HSI and
FSI efficiencies on a nucleosome structure is very informative on
the catalytic process and suggests a simultaneous strand transfer
reaction of the two viral strands in the acceptor DNA. This
reaction would be strongly disfavored on a DNA structure closely
wrapped around a native nucleosome structure, but, as we will
discuss below, could be favored on a remodeled nucleosome.
A recent crystallization of the full length prototype foamy virus
integrase and the derived HIV-1 integrase structural model
suggests that the binding of a nucleosomal DNA to the intasome
containing a tetrameric IN bound to two viral ends would require
at least local remodeling for two-end concerted integration ([53]
and personal communication from P. Cherepanov). In this model
the nucleosome structure could decrease the access and flexibility
of the DNA helix necessary for the concerted integration (even if
the 4–6 bp stagger is an indicator of major groove recognition).
Our full-site integration data obtained on chromatinized templates
indicate that a labile chromatin structure is a better substrate for
retroviral integration than a stable nucleosome domain. This
confirms that a dynamic chromatin structure can allow the loci to
adapt for two viral-ends integration, nucleosomes being more
easily displaced in this context or DNA on nucleosomes being
more labile and accessible for the intasome. Several factors
interacting with chromatin were found to interact with IN such as
the widely reported INI1 [21] and LEDGF/p75 [26,54,55] in
addition to other proteins [56,57]. Such a factor could compensate
the natural anti-integration property of the stable chromatin,
hence allowing the IN enzyme to accommodate the physical
constraints within this region. This is supported by the inefficiency
reported here of the physiological concerted integration reaction in
a region where nucleosomes are dense and stable. Transcription
and nucleosome remodeling factors are good candidates for this
function because they help the DNA wrapped around histones to
become accessible for integration. Since the SWI/SNF complex
contains INI1 and exerts chromatin remodeling activity in the cell,
we focused our work on the effect of this complex on integration
using our new in vitro concerted integration assay into chromatin.
The use of purified SWI/SNF complexe in our integration
assays with a nucleosome substrate clearly showed that efficient
remodeling allows the recovery of efficient FSI (see Figure 4).
More importantly, the sequencing of the integration loci in the
presence of the SWI/SNF complex indicated that it specifically
targeted the integration events towards the stably associated
nucleosome region in an ATP-dependent manner, demonstrating
that the chromatin remodeling activity of the complex was
required for the process. This was confirmed by the fact that the
isolated INI1, which was still able to bind IN but without
catalyzing the remodeling activity, was not sufficient for restoring
integration into this PN.
The targeting of integration into chromatin region I after SWI/
SNF remodeling could be due to several causes. A decrease in the
DNA accessibility in region II or a better accessibility of region I
versus region II after remodeling were ruled out by restriction
analysis (data not shown). Since the main difference between
region I and region II is the stability and organisation of the
nucleosomes these properties should explain the favoured
integration in the region I if a direct coupling occurs. The
previously reported direct INNINI1 interaction [21], the interac-
tion between IN and the SWI/SNF complex demonstrated here
by in vitro co-immunoprecipitation (Figure 5A) and the require-
ment for this interaction in the restoration process support this
hypothesis. Our results led us to propose a direct targeting of IN to
the remodeled loci or an interaction between the IN and SWI/
SNF-enriched region I.
This is supported by the recent demonstration that IN and INI1
also interact in a cellular context [58]. In order to answer the
question about the role of INI1 in the mechanism of restoration,
we tested two active remodeling human factors that don’t bind
directly to IN. We first tested the SNF2H subunit of the ACF-
SNF2H complex, for its effect on integration into the PN
templates. As reported in Figures 5C no interaction was detected
in vitro between HIV-1 IN and SNF2H. In addition SNF2H was
found able to remodel our PN template with the same efficiency
than SWI/SNF (see Figure S10). However, despite this remodeling
activity, no restoration of integration was detected on the PN
treated by SNF2H (Figure 5D). We also analyzed the effect of
BRG1, the active subunit of SWI/SNF, lacking the integrase
binding cofactor INI1, but having similar remodeling efficiency as
Figure 7. Correlation between in vivo HIV-1 integration site and
nucleosome occupancy. 41435 integration loci were obtained from
[12] and submitted to the nucleosome-positioning prediction analysis
set up previously [39]. The predicted high-density (1 nuc./200 bp.)
nucleosome occupancy was reported and the position of the
integration site was plotted as dotted line. Comparison between the
intragenic and intergenic integration sites is reported. Results are the
means of the analyses performed from the 41435 integrands. Data
correspond to the nucleosome occupancy averaged over integration
sites in 9017 intergenic regions (grey) and 32418 genic regions (red).
doi:10.1371/journal.ppat.1001280.g007
HIV-1 Integration into Stable Chromatin
PLoS Pathogens | www.plospathogens.org 9 February 2011 | Volume 7 | Issue 2 | e1001280
the whole complex. As reported in the Figure. 6A, despite an
efficient remodeling of the template, no restoration of integration
was detected.
Taken together our data indicate that the direct interaction
between IN and the whole active SWI/SNF complex is required
for the integration into stably associated PN. Even if the
involvement of the INI1NIN interaction in the process remains to
be proved the literature data as well and our own data suggest that
INI1 could be the bridge for the coupling between the integration
and chromatin remodeling, at least in in vitro integration assays. To
our knowledge this is the first direct evidence of functional
coupling between chromatin remodeling and retroviral integra-
tion.
According to this model the region I should constitute a
preferred environment for integration after remodeling by SWI/
SNF. The DNA accessibility is not sufficient to explain this process
since, after remodeling, the region I was still found less accessible
than the region II in REA analyses (data not shown). Thus, the
simplest explanation for the integration restoration appears an
enrichment of the region I with active SWI/SNF complexes due to
the less dynamic and more stable properties of the nucleosomes in
this domain. However the accurate mechanism of region I
remodeling by SWI/SNF is not known and, more generally, the
remodeling processes are still under debate in the field. Further
structural analyzes of the active HIV-1 intasome complexed to a
nucleosome would bring very useful information about the way
nucleosome and intasome fit to accommodate with the physical
constraints of this chromatin structure.
The involvement of the SWI/SNF complex in HIV-1
replication was previously studied mainly using RNA silencing
approaches. Those studies suggest that INI1 could participate in
several steps of the retroviral biological including nuclear import of
the PIC, integration, transcription and virion production
[24,43,58]. Several studies also showed that INI1 is not necessary
for retroviral replication, but the efficiency of silencing of the INI1
genes as well as their impact on the entire SWI/SNF complex
remain unclear. The latter point is crucial since it has been
reported that the in vitro effect of INI1 on integration can vary from
stimulation to inhibition depending of its concentration. The
precise function of this factor in the replication cycle remains
unclear so the cellular situation requires further analysis.
In silico comparison of 41 435 integration loci previously selected
in infected cells [12] with nucleosome occupancy prediction using
the method described by Milani et al. [39] also supports our in vitro
data. Actually this model provides very similar performance in
predicting the sequence dependent nucleosome positioning as the
recent one developed by Field et al. [59] which corresponds to a
significant improvement of the former Segal model [60]. As
demonstrated by Tillo D. et al. [61], the Segal model indeed
poorly accounts for the nucleosome positioning profile as observed
in Yeast and other species. This new powerful predictive algorithm
based on the combination of atomic force microscopy and
theoretical modeling demonstrated the existence of major
sequence signaling in vivo which involves high-energy barriers
locally inhibiting nucleosome formation [39]. Analysis of the
cellular integration loci showed that they were disfavored in dense
and stable nucleosome regions, as observed in region I of our in
vitro PN templates. Even if several hypotheses can explain this
apparent selectivity in the cell, these data are consistent with the
results obtained in our in vitro studies system and correlate with the
integration refractory property of stable chromatin found in this
model.
The cellular situation has been more widely studied by massive
analysis of retroviral DNA integration with a pyrosequencing
method [12,19,20]. In those studies, computational prediction of
nucleosome positions in target DNA indicated that integration
was particularly promoted near transcription-associated histone
modifications, including H3 acetylation, H4 acetylation and H3
K4 methylation, but was not promoted in regions rich in
transcription-inhibiting modifications, which include H3 K27
trimethylation and DNA CpG methylation. These data are
consistent with our in vitro observation and suggest that the
functional link between HIV-1 IN and cellular chromatin
remodeling complexes described in vitro can also occur in the
infected cells. Such functional interactions between both viral
integration and cellular chromatin remodeling complexes are not
limited to HIV-1. A strongly biased target-site selection was
found for yeast Ty3 retrotransposons. Ty3 integration is
promoted at the 59 ends of RNA polymerase-III-transcribed
genes via interaction between IN and RNA polymerase III
transcription factors [62]. More striking examples are found for
yeast TY1 retrotransposons integration, where chromatin re-
modeling is associated with the selectivity of integration [63,64].
Ty1 inserts into an approximately 700-bp integration window
upstream of tRNA genes approximately every 80 bp. ATP-
dependent chromatin remodeling by Isw2 upstream of tRNA
genes leads to changes in chromatin structure and Ty1
integration site selection. These data could indicate that these
mechanisms could be more widespread in the field of viral DNA
mobility.
Our data lead us to propose an integration/remodeling
coupling model presented in Figure 8. Early interaction between
the incoming viral preintegration and the SWI/SNF remodeling
complexes could favor a targeted integration into actively
remodeled chromatin which would thus constitutes preferential
sites (Figure 8, path iii). An alternative mechanism could be the
interaction between the integration complex and the SWI/SNF-
enriched regions of the genomes under remodeling (Figure 8, path
ii). Previous works reported the early interaction between IN, viral
DNA and INI1 as well as the incorporation of this factor into
HIV-1 virions [24,43]. This is consistent with a role of INI1 in the
early events of replication and with the possible early interaction
between the factor and the incoming PIC, leading both to nuclear
entry and targeting to the SWI/SNF-enriched region of the host
DNA (Figure 8, path iv). All these non-exclusive ways could lead to
the formation of a bifunctional chromatin remodeling-integration
complex. Alternatively, remodeling of the nucleosome structure by
the whole active SWI/SNF complex associated with activation of
transcription could promote the integration steps by promoting a
chromatin structure compatible for integration (DNA bulges,
histone modifications etc…) (Figure 8, path v).
The exact structure of DNA in the remodeled integration site
remains to be determined in order to elucidate whether integration
takes place in DNA bulges formed around the nucleosome after
remodeling or in naked DNA obtained after sliding of the
nucleosome or ejection of the histone octamer. Our data are not
inconsistent with a preferential integration into nucleosomes as
shown by the previous wild range analyses of cellular integration
loci reported by Bushman, but they also reveal that HIV-1
integration preferentially into a more labile region of the genome
where the DNA structure can be more easily adapted during
remodeling to fit with the intasome constraints for efficient
integration. This model is also compatible with the involvement of
additional cellular chromatin-binding factors, such as LEDGF/
p75 or other transcription factors that could refine the control of
integration targeting. The in vitro system reported here should
allow extensive analysis of the impact of such factors in both the
specificity and selectivity of HIV-1 integration into chromatin.
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Materials and Methods
Proteins
HIV-1 IN standard purification was performed as previously
described [35]. Purification of SWI/SNF was done as previously
reported [47]. Nuclear extracts were prepared from a HeLa S3 cell
line expressing Flag-tagged INI1 as described before [65]. Affinity
purification of the eptitope-tagged SWI/SNF complex was
performed from these extracts as described previously [46]. Flag-
tagged INI1 and BRG1 were produced in SF9 cells using a
baculovirus overexpression system and purified on M2-agarose
beads according to previously described protocols [66]. The purity
of these proteins was checked by SDS-PAGE and the remodeling
activity of Flag-BRG1 was controlled by REA on a linear PN
template assembled on the 5S-G5E4 fragment and on the pBSK-
zeo-5S-G5E4 vector. Flag tagged SNF2H was a kind gift from G.
Narlikar (UCSF, USA) and prepared as described previously [49].
DNA substrates
Both target and pBSK-zeo donor plasmids and the 296 bp
unprocessed donor were described before [35]. The 2.56 kb 5S-
G5E4 fragment DNA for polynucleosome assembly (PN) was
previously described [34]. It is made of two times five repeats of 5S
sequences surrounding a central sequence containing five gal4
DNA binding sites and the adenovirus 2 E4 minimal promoter.
We constructed a new circular acceptor template (Figure S1A) by
cloning the 5S-G5E4 fragment into the pBSK-zeo vector at KpnI
and SacI positions. Polynucleosome templates were assembled with
purified HeLa core histones [67] by gradient salt dialysis [47] or
using the Acf1/ISWI dependent ‘‘Chromatin Assembly Kit’’ from
MILLIPORE following the manufacturer protocol. Structure of
regions I and II was checked by ab initio prediction of nucleosome
occupancy throughout the DNA sequence performed by comput-
ing the free-energy landscape associated with the bending of DNA
around histone octamers to form nucleosomes (Figure 1C). The
mathematical method is described in detail in [40,68]. Nucleo-
some assembly on the vector was checked by mono- and di-
nucleosome gel shift (S1B) as performed before [34] and REA
assay [69] as described [50] (Figure 1D).
Concerted integration
Standard concerted integration reactions were performed as
described previously [35] using purified HIV-1 IN (12 pmoles), 59-
end-labeled donor DNA (10 ng) and circular target DNA plasmids
pBSK-zeo or pBSK-zeo-5S-G5E4 (100 ng). A typical integration
reaction is described in Figure S2. After reaction, integration
products were loaded on 1% agarose gel, dried and autoradio-
graphied. Quantification of the integration activity was performed
using the Image J software with the following procedure: the bands
corresponding to the free substrate (S), the donor/donor (d/d),
linear FSI (FSI) and circular HSI+FSI (HSI+FSI) were quantified.
The percentage of HSI+FSI integration activity was determined as
(HSI+FSI)/[(FSI)+(HSI+FSI)+(d/d)+(S)]6100. Percentage of FSI
integration activity was determined as (FSI)/[(FSI)+(HSI+FSI)+(d/
d)+(S)] 6100. Previous analyses showed that the linear FSI
products was be representative of the circular FSI form, thus it was
Figure 8. Model for HIV-1 integration into stable chromatin regions. HIV-1 integration appears disfavored in stably associated and dense
nucleosome regions both in vitro and in vivo (i). However, functional interaction between IN and the SWI/SNF remodeling activity could allow the
integration into the nucleosome-dense region of the chromatin either by serving as chromatin receptor for the intasome (ii) either by targeting the
intasome into region of the host DNA to be remodeled (iii). Early interaction between IN and INI1, including in virions, could make it possible to direct
the intasome in the same SWI/SNF-enriched region (iV). All these non-exclusive ways could lead to the formation of the same integration-remodeling
complex for remodeling the integration loci and thus either to accommodate the intasome with the structural constraints of the nucleosome or to
allow integration into a local nucleosome-free segment. Finally, SWI/SNF remodeling of the nucleosome structure could lead to the formation of an
integration-promoted structure (hatched nucleosomes) and target the integrase and/or catalytic activity of integrase on the PN template (V).
doi:10.1371/journal.ppat.1001280.g008
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used to determine the global FSI activity. FSI reaction was
additionally quantified by cloning the integration products into
bacteria using the same protocol as described previously [51].
Briefly, after concerted integration, the products were purified on
a DNA purification system column (Promega) as described by the
supplier and then introduced into a MC1060/P3 E. coli strain
which contained ampicillin-, tetracycline- and kanamycin-resis-
tance genes. Both ampicillin- and tetracycline-resistance genes
carry an amb mutation. These proteins are thus expressed only in
the presence of supF gene products. Integration clones carrying the
supF gene were therefore selected in the presence of 40 mg/ml
ampicillin, 10 mg/ml tetracycline and 15 mg/ml kanamycin. The
integration loci determination was performed by isolating plasmids
from quadruple-resistant colonies and PCR sequencing (ABI
Prism big dye terminator cycle sequencing ready reaction kit,
Applied Biosystems) using the U3 primer (59-TATGGAAGGGC-
TAATTCACT-39) and the U5 primer (59-TATGCTAGA-
GATTTTCCACA-39). Only the integration products containing
the 5 bp repeats flanking the integrated DNA were reported for
localization in the acceptor DNA sequence.
In vitro chromatin remodeling
Remodeling of the PN templates was performed with purified
human SWI/SNF complex or with the BRG1 or SNF2H
enzymes. 0.8, 0.6 or 1 pmoles of respectively purified SWI/SNF
complex, BRG1 or SNF2H enzymes were incubated with 100 ng
of acceptor DNA for 0 to 120 minutes at 30uC in a 10 ml reaction
volume of buffer containing 2 mM ATP, 2 mM free MgCl2,
1 mM DTT, 10 mM Hepes, pH 7.5, 0.1 mM EDTA, 60 mM
KCl. Remodeling was checked by REA assay [69] as described
[50]. For coupling to concerted integration the recombinant IN
(12 pmoles) was added to the remodeling reaction with the donor
DNA (10 ng) and the complexes were formed for 20 minutes at
0uC. The integration reaction buffer was then added to reach the
optimal IN activity (20 mM HEPES, pH 7.5; 10 mM DTT;
10 mM MgCl2; 15% DMSO; 8% PEG, 30 mM NaCl) and the
reaction was carried out as described above. Remodeling activity
was measured by REA assays [69] as described [50]. Assays were
done in a buffer containing 12 mM Hepes (pH 7,9), 60 mM KCl,
1 mM DTT, 12% glycerol, 0.1 mM EDTA and 2 mM ATP in
presence of 10 to 15 units of HhaI enzyme at 30uC. Typically
4 nM of DNA substrate were used in the final reaction with 0.8
pmoles of SWI/SNF for 120 minutes. The reaction was stopped
by digestion with 1 mg/ml of proteinase K in presence of SDS and
EDTA at 37uC for 30 min. The samples were then submitted to
phenol/isoamyl alcohol/chlorophorm (24/1/25 v/v/v) extraction
and analyzed on 1% agarose gels.
In vitro co-immunoprecipitation
12 pmoles of pure recombinant integrase was mixed with either
0.2 pmoles of SWI/SNF complex, 6.2 pmoles of FLAG tagged
INI1 or 2,7 pmoles of SNF2H protein and incubated at 37uC for
1 hour. Then rabbit polyclonal anti-BAF57/SMARCE1 (a-
BAF57) (Abcam ab70540), mouse monoclonal anti-FLAG (a-
FLAG) (Sigma Aldrich F1804) or rabbit polyclonal anti-SNF2h (a-
SNF2H) (Abcam ab72499) antibodies or no antibodies were added
to the mixture at 4uC over night. Following a 1 h 30 incubation
with BSA-saturated sheep anti-rabbit/mouse IgG magnetic beads
(Invitrogen Dynabeads M-280) at 4uC, the samples were washed
two times with an excess of PBS BSA 1%. The samples were
subjected to SDS-PAGE electrophoresis after addition of Urea-
SDS buffer. The membranes were immunoblotted with either a-
BAF57, a-FLAG, a-SNF2H or rabbit polyclonal anti-integrase
antibodies (Bio Products MD, AB-INT 100), and HRP-conjugated
secondary antibodies
Nucleosome occupancy prediction
Nucleosome occupancy prediction was determined using the
method previously described by [39].
Supporting Information
Figure S1 Structure of the pBSK-zeo-5S-G5E4 chromatinized
acceptor DNA. The position of the restriction sites used in REA
assays are reported in the pBSK-zeo-5S-G5E4 sequence (A).
EcoR1 restriction was used to control the structure of the
nucleosome 5S-G5E4 domain on 0.8% agarose gel. We report
the 5S mononucleosome (5S MN), GSE4 431 bp DNA and 5S
196 bp fragment in addition to polynucleosome fragments (PN)
and pBSK-zeo DNA vector backbone positions of the correspond-
ing bands for each restriction analysis of the 1/1, 1/1.33, 1/1.67
and 1/2 polynucleosomial pBSK-zeo-5S-G5E4 in addition to the
naked corresponding pBSK-zeo-5S-G5E4 vector. Agarose gel shift
structure analysis performed after EcoRI restriction one set of
acceptor DNA is shown in (B).
Found at: doi:10.1371/journal.ppat.1001280.s001 (0.67 MB TIF)
Figure S2 Standard in vitro concerted integration assay.
Standard concerted integration reactions were performed as
described previously using purified HIV-1 IN (12 pmoles), 59-
end-labeled donor DNA (100 ng) and circular receptor DNA
plasmids pBSK-zeo. The donor DNA contains 20 terminal base
pair derived from the viral U3 and U5 end. The receptor DNA
contains a SupF gene suppressing the amb mutation under the
dependence of the bacterial EM7 promoter. This is used for
selecting integrants in the MC1060/P3 E. coli strain which
contained ampicillin- and tetracycline-resistance genes carrying
the amb mutation. IN was incubated 20 minutes at 4uC with both
the donor and the receptor DNA before adding the reaction
mixture (20 mM HEPES, pH 7.5; 10 mM DTT; 10 mM MgCl2;
15% DMSO; 8% PEG, 30 mM NaCl) in a final volume of 10 ml.
The reaction is proceeded for 90 min at 37uC. Incubation was
stopped by adding a phenol/isoamyl alcohol/chloroform mix (24/
1/25 v/v/v). The aqueous phase was loaded on a vertical 1%
agarose gel in the presence of 1% bromophenol blue and 1 mM
EDTA. After separation of the products, the gel was treated with
5% TCA for 20 min, dried and autoradiographed. After reaction
three types of products are detected: donor/donor products
corresponding to the strand transfer of one viral end from one
donor molecule to another one, circular half site (HSI) products
corresponding to the strand transfer of one viral end from one
donor molecule to a circular acceptor plasmid, circular full site
(FSI) products corresponding to the strand transfer of two viral
ends from the same donor molecule to a circular acceptor plasmid
and linear FSI corresponding to the strand transfer of two viral
ends from two independent donor molecules to a circular acceptor
plasmid leading to its linearization. The circular FSI and HSI can
not be distinguished on gel but the circular FSI can be specifically
cloned into bacteria and sequenced allowing its specific quanti-
fication and the determination of both the structure of the
integrated DNA and its localization into the target DNA. Here are
reported the products detected on agarose gel after reaction
performed without IN (lane 1), without acceptor DNA (lane 2) and
in presence of all the constituents of the reaction (lane 3).
Found at: doi:10.1371/journal.ppat.1001280.s002 (0.36 MB TIF)
Figure S3 Effect of nucleosome assembly on structure of
integration loci. A concerted integration assay was performed
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with 12 pmoles of IN and 100 ng of donor DNA and 10 ng of
naked pBSK-zeo-5S-G5EA plasmid (Naked), or polynucleosomal
pBSK-zeo-5S-G5E4 assembled with increasing amounts of
histones expressed in DNA/histones mass ratio (mg/mg) (1/1, 1/
33, 1/167, 1/2). The circular FSI products were specifically
quantified by cloning in bacteria and reported as the number of
ampicillin-, kanamycin- and tetracycline-resistant selected clones.
100 FSI products obtained after integration in each condition were
sequenced by PCR (ABI Prism big dye terminator cycle
sequencing ready reaction kit, Applied Biosystems) using the U3
primer (59-TATGGAAGGGCTAATTCACT-39) and the U5
primer (59-TATGCTAGAGATTTTCCACA-39). The number
of correct 5 bp duplications or other events (including other
duplications or deletions) found at the extremity of the integrated
DNA was reported. Not enough integrants were selected with the
1/2 PN plasmid (nd).
Found at: doi:10.1371/journal.ppat.1001280.s003 (0.08 MB TIF)
Figure S4 Effect of nucleosome assembly on in vitro HIV-1
integration into pBSK-zeo acceptor plasmid. A concerted
integration assay was performed with 12 pmoles of IN and
100 ng of donor DNA and 10 ng of naked pBSK-zeo acceptor
plasmid lacking the 5S-G5E4 sequence assembled with increasing
amounts of mass ratios (mg/mg) of DNA/histones (lanes 1/1, 1/33,
1/1.67, 1/2). The reaction products were loaded on 1% agarose
gel (A). The position and structures of the donor substrate and
different products obtained after half-site (HSI), full-site (FSI) and
donor/donor integration (d/d) are shown. The different integra-
tion products were quantified by densitometric estimation of the
FSI and HSI+FSI heterointegration bands with the Image J
software (B). The circular FSI products were specifically quantified
by cloning in bacteria and reported as the number of ampicillin-,
kanamycin- and tetracycline-resistant selected clones (C). All the
values correspond to the mean6 standard deviation (error bars) of
three independent sets of experiments.
Found at: doi:10.1371/journal.ppat.1001280.s004 (0.65 MB TIF)
Figure S5 Effect of Acf1/ISWI assembled nucleosomes on
concerted integration. Acf1/ISWI assembly was performed in
presence of recombinant histone chaperone NAP-1 and topoisom-
erase following the manufacturer protocol (MILIPORE). Assembly
on the pBSK-zeo-5S-G5E4 vector was checked by REA assay (a
typical representative experiment is reported in A). A concerted
integration assay was then performed with 12 pmoles of IN and
100 ng of donor DNA and 10 ng of pBSK-zeo-5S-G5EA plasmid
(Naked), or polynucleosomal pBSK-zeo-5S-G5E4 assembled with
increasing amounts of histones expressed in DNA/histones mass
ratio (mg/mg) (1/0.2, 1/0.6). The reaction products were loaded on
1% agarose gel and the different integration products were
quantified by densitometric estimation of the FSI and HSI+FSI
heterointegration bands with the Image J software (B).
Found at: doi:10.1371/journal.ppat.1001280.s005 (0.13 MB TIF)
Figure S6 Effect of DNA relaxation on in vitro integration into
naked or polynucleosomal acceptor template. A concerted
integration assay was performed with 12 pmoles of IN and
100 ng of donor DNA and 10 ng of naked pBSK-zeo-5S-G5EA
plasmid (Naked), or polynucleosomal pBSK-zeo-5S-G5E4 after
treatment of not with topoisomerase I. Relaxation was checked by
agarose gel analysis after proteinase K and Phenol-chloroforme-
isoamyla alcohol (24/25/1, v/v/v) treatment (an example of
analysis is shown in the bottom of panel A). The reaction products
were loaded on 1% agarose gel and the FSI heterointegration
product was quantified with the Image J software. An example of
results obtained with the naked and 1/33 PN is shown in the top of
panel (A) and quantification means 6 standard deviation (error
bars) of three independent sets of experiments performed with the
set of plasmids assembled with increasing amounts of histones
expressed in DNA/histones mass ratio (mg/mg) (1/1, 1/33, 1/167,
1/2) are shown in (B). OC: relaxed open circular form of the
plasmid, CC: compacted closed circular form of the plasmid.
Found at: doi:10.1371/journal.ppat.1001280.s006 (0.34 MB TIF)
Figure S7 Effect of nucleosome assembly on integration loci
distribution in pBSK-zeo-5S-G5EA acceptor plasmid. A concerted
integration assay was performed with 12 pmoles of IN and 100 ng
of donor DNA and 10 ng of naked pBSK-zeo-5S-G5EA plasmid
(Naked), or polynucleosomal pBSK-zeo-5S-G5E4 assembled with
a 1/1.67 DNA/histones mass ratio. The circular FSI products
were cloned bacteria and were sequenced for each condition. 20
correct integration loci (IL) were localized in the naked pBSK-zeo-
5S-G5EA (A) and polynucleosomal pBSK-zeo-5S-G5E4 (B) vector
sequence.
Found at: doi:10.1371/journal.ppat.1001280.s007 (0.32 MB TIF)
Figure S8 Effect of chromatin remodeling activity of SWI/SNF
complex on in vitro integration in nucleosomal templates. Naked or
chromatinized pBSK-zeo-5S-G5EA vectors assembled with in-
creasing amounts of histones expressed in DNA/histones mass
ratio (mg/mg) (1/1, 1/33, 1/167, 1/2) were treated with or without
SWI/SNF in presence or not of ATP. The remodeling efficiency
was controlled in a REA assay using HhaI restriction enzyme. The
percentage of cleavage is shown for each condition in (A). A
concerted integration assay was performed with 12 pmoles of IN
and 100 ng of donor DNA and 10 ng of naked pBSK-zeo-5S-
G5EA plasmid (Naked), or polynucleosomal pBSK-zeo-5S-G5E4
assembled with increasing amounts of histones expressed as DNA/
histones mass ratio (mg/mg (1/33 and 1/2) after 0 to 120 min of
SWI/SNF treatment in presence of ATP. The reaction products
were loaded on 1% agarose gel (B). The position of the donor
substrate and different products obtained after half-site (HSI), full-
site (FSI) and donor/donor integration (d/d) are shown. The
circular FSI products obtained with all the set of chromatinized
plasmids after SWI/SNF treatment in presence of ATP were
cloned into bacteria 100 integration loci were sequenced. The
number of correct 5 bp duplications or other events (including
other duplications or deletions) found at the extremity of the
integrated DNA are shown in (C).
Found at: doi:10.1371/journal.ppat.1001280.s008 (0.42 MB TIF)
Figure S9 Effect of chromatin remodeling activity of SWI/SNF
complex on integration loci distribution in pBSK-zeo-5S-G5EA
acceptor plasmids. A concerted integration assay was performed
with 12 pmoles of IN and 100 ng of donor DNA and 10 ng of
naked pBSK-zeo-5S-G5EA plasmid (Naked) (A), or polynucleoso-
mal pBSK-zeo-5S-G5E4 assembled with a 1/1.67 DNA/histones
mass ratio and treated with SWI/SNF complex in presence (B) or
not of ATP (C). The circular FSI products were cloned bacteria
and were sequenced for each condition, and 20 correct integration
loci (IL) were localized in the vector sequence.
Found at: doi:10.1371/journal.ppat.1001280.s009 (0.47 MB TIF)
Figure S10 In vitro remodeling activity of human SNF2H on
pBSK-zeo-5S-G5E4 vectors. Naked or chromatinized pBSK-zeo-
5S-G5EA vectors assembled by salt dialysis with increasing
amounts of histones expressed in DNA/histones mass ratio (mg/
mg) (1/1, 1/33, 1/167, 1/2) were treated with or without SNF2H
in presence or not of ATP. The remodeling efficiency was
controlled in a REA assay using HhaI restriction enzyme. The
percentage of cleavage is shown for each condition. The result of a
typical experiment is shown.
Found at: doi:10.1371/journal.ppat.1001280.s010 (0.13 MB TIF)
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